CorMedix (CRMD)

• Market cap: $617M
• 1 day: -2.24%
• 5 days: -7.19%
• 1 month: -6.2%
• 3 months: 6.06%
• 6 months: 1.42%
• Year to date: -35.28%
• 1 year: -31.57%
• 5 years: 29.44%
• 10 years: 12.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 191